BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3872793)

  • 1. Interpretive criteria for temocillin disk diffusion susceptibility testing.
    Fuchs PC; Barry AL; Thornsberry C; Jones RN
    Eur J Clin Microbiol; 1985 Feb; 4(1):30-3. PubMed ID: 3872793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks.
    Zerva L; Biedenbach DJ; Jones RN
    J Clin Microbiol; 1996 Aug; 34(8):1970-4. PubMed ID: 8818892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility of bovine mastitis pathogens to a combination of penicillin and framycetin: development of interpretive criteria for testing by broth microdilution and disk diffusion.
    Pillar CM; Stoneburner A; Shinabarger DL; Abbeloos E; Goby L; Bradley AJ
    J Dairy Sci; 2014 Oct; 97(10):6594-607. PubMed ID: 25129497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of interpretive criteria for tebipenem disk diffusion susceptibility testing with Staphylococcus spp. and Haemophilus influenzae.
    Fujisaki M; Sadamoto S; Ikedo M; Totsuka K; Kaku M; Tateda K; Hirakata Y; Yamaguchi K
    J Infect Chemother; 2011 Feb; 17(1):17-23. PubMed ID: 20676913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mezlocillin: tentative interpretive standards for disk diffusion susceptibility testing.
    Fuchs PC; Barry AL; Thornsberry C; Jones RN; Gerlack EH
    Antimicrob Agents Chemother; 1981 Aug; 20(2):197-203. PubMed ID: 6456689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposed changes in interpretive criteria and potency of ampicillin and ampicillin-sulbactam disks for susceptibility tests.
    Barry AL; Jones RN
    J Clin Microbiol; 1988 Apr; 26(4):750-4. PubMed ID: 3130390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperacillin susceptibility tests by the single-disk agar diffusion technique.
    Barry AL; Thornsberry C; Badal RE; Baker CN; Jones RN; Gerlach EH
    Antimicrob Agents Chemother; 1979 Sep; 16(3):378-85. PubMed ID: 507794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial activity of coumermycin and recommendations for disk diffusion tests with 5- and 15-micrograms disks.
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1987 May; 7(1):77-82. PubMed ID: 3691036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830).
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1989; 12(6):495-510. PubMed ID: 2560422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disk diffusion susceptibility testing of ticarcillin plus clavulanic acid.
    Fuchs PC; Jones RN; Barry AL; Thornsberry C
    J Clin Microbiol; 1984 Apr; 19(4):555-7. PubMed ID: 6715524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality control parameters and interpretive criteria for in vitro susceptibility tests with the macrolide azithromycin. Collaborative Antimicrobial Susceptibility Testing Group.
    Barry AL; Thornsberry C; Gavan TL
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):544-9. PubMed ID: 2548865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to cefditoren, and provisional interpretive criteria.
    Fuchs PC; Barry AL; Brown SD
    Diagn Microbiol Infect Dis; 2000 Aug; 37(4):265-9. PubMed ID: 10974578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disks.
    Barry AL; Fass RJ; Anhalt JP; Neu HC; Thornsberry C; Tilton RC; Painter BG; Washington JA
    J Clin Microbiol; 1985 Jun; 21(6):880-3. PubMed ID: 3159749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefixime disk susceptibility test criteria.
    Fuchs PC; Barry AL; Jones RN
    J Clin Microbiol; 1986 Oct; 24(4):647-9. PubMed ID: 3771755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteria.
    Fuchs PC; Barry AL; Jones RN; Thornsberry C; Ayers LW; Gavan TL; Gerlach EH
    Diagn Microbiol Infect Dis; 1987 Mar; 6(3):185-92. PubMed ID: 3471371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic.
    Fuchs PC; Jones RN; Barry AL
    J Clin Microbiol; 1990 Mar; 28(3):608-9. PubMed ID: 2108997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftriaxone: a summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-micrograms disks.
    Jones RN; Barry AL; Thornsberry C
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):295-311. PubMed ID: 6321093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison and evaluation of ticarcillin and carbenicillin using disk diffusion methods.
    Parry MF; Neu HC
    Antimicrob Agents Chemother; 1976 Apr; 9(4):625-32. PubMed ID: 817662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interpretive criteria and tentative quality control limits for apalcillin disk susceptibility tests.
    Barry AL; Thornsberry C; Jones RN; Gavan TL
    J Clin Microbiol; 1984 Jun; 19(6):777-82. PubMed ID: 6432833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cefadroxil and cephalothin disk susceptibility test results.
    Barry AL; Jones RN
    J Clin Microbiol; 1989 Jul; 27(7):1460-3. PubMed ID: 2504768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.